Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
After hours PR for CYDY announcing EUA approval, UK approval, NASDAQ uplist could come at anytime. These are currently under review and announcement could come at any moment.
Yes they do, every day at multiple hospitals across the United States. And now doctors are giving shots of Leronlimab in hospitals in the UK. The UK is so impressed with the positive results they are speaking with CytoDyn tomorrow to discuss a path to market for Leronlimab.
So MHRA requested the meeting with CytoDyn not only to talk about CD10 but also to discuss the eIND patients. Presenting this much positive data points to an approval.
MHRA approval at the end of the week will launch CYDY to $15, or FDA EUA approval comes before that and we see $25 then MHRA and NASDAQ move it to $30
Up 10% and vaccine stocks are tanking. This looks like word leaked from FDA that Leronlimab is approved from EUA.
Wasn't even talking about you, but hey you obviously thought I was.
You conviently leave out they are also discussing eIND patients. Looking at all the data from Leronlimab showing outstanding positive results will guarantee an approval.
Not only the meeting with MHRA, CD10 EUA approval is still under review with the FDA. Most likely EUA has been approved and will be announced at any moment.
The meeting Wednesday with MHRA will be a game changer. Not only did MHRA request the meeting with CytoDyn they also want to discuss eIND patients. The absolutely incredible results from CD10 combined with eIND patients will earn an approval.
Hey justdafactss, when CytoDyn brings Leronlimab to market in the UK how soon does revenue start rolling in? With OWS getting involved and immediately funding companies could be as soon as this month maybe October?
CD10 is still currently under review by the FDA for EUA approval. With the strong positive results the trial has shown it is expected to gain approval. This could happen at any moment now, and after approval OWS will be involved for production and distribution. In the meantime CytoDyn is meeting with the UK to discuss a path to bring Leronlimab to market.
Further improvement in the indicators. The 100 day MA crosses over and is positive. MACD inches a little higher but still below the neutral line ( -20 ). RSI is positive.
Look closely at the O/B O/S indicator this show CYDY as a strong buy, respect the history of what has occurred with CYDY when it reached $10 and is heading there again. It has continued to climb, this is a precursor to setting a new high.
As to the Overall Trend it remains positive.
d0lphint0m just posted some very impressive charts. His T/A has always been spot on. You haven't debunked anything. His charts prove your words are wrong.
*cow clothing
With CYDY current strong uptrend the question is what's driving it. The meeting with UK to discuss a path to bring Leronlimab to market, or the fact that FDA EUA is still on the table and could be approved at any moment.
CYDY is in a strong uptrend
There's more conversation about CYDY than HGEN on HGEN's board. They sound terrified and obsessed with CYDY. All this while HGEN SP is tanking.
The strong uptrend of CYDY looks to be from news that CytoDyn is meeting with the UK to discuss a path to bring Leronlimab to market.
Hey cowtown, when CYDY gets approval do you think HGEN will tank even further? It's pretty low right now. Not looking good over there.
The upward trend of CYDY shows the market is accepting of the meeting between CytoDyn and the UK to discuss a pathway to market for Leronlimab. This upward trend will continue with a PT of $5.95 then after approval $15.
Technical analysis for CYDY
The price went up the price went down....see guys I was right!! guys...guys...please somebody notice I was right!.....guys?
Certain individuals at the FDA should be thinking long and hard if they want to end up sitting in front of a congressional hearing answering why it took so long to approve Leronlimab.
Look at that, the price is going up. Must be in anticipation of CytoDyn's meeting with the UK to discuss the path to bring Leronlimab to market in the UK. That's going to be an oh shit moment for the FDA, they're going to panic when an American company gets approval in Europe before the U.S.
The investor could have chose to short CYDY with their 2 million dollar investment but that didn't happen they invested by buying 2 million dollars worth of shares. Only a fool would try to short CYDY. The smart move is to buy shares.
The 500,000 share buy, an investment of $1,950,000 is in anticipation of the UK approval coming next week. Should profit the investor about $6 million dollars. Easy money.
They are buying, two 250,000 buy orders today CYDY
When UK approves CD10 next week that should put CYDY at $15 then the FDA will approve and that pushes it to $30
Hey Justdafactss when CD10 is approved what will the chart say for CYDY $15, $20, $30
Another thing to keep in mind Gilead through the course of time had to spend hundreds of millions on R&D for various different drugs. CytoDyn will accomplish this with only having to finance clinical trials, and not even that for some with expanded use.
The Chicken Little longs that sold yesterday are sweating it this morning. They expected to hear EUA denied, with that still on the table it could be approved at any moment.
LOL, this wins post of the day!
I'm starting to understand this whole T/A thing with reading the charts. When CYDY is in a downtrend that means it will spike up 10%. Crazy doesn't make sense, but oh well, I guess it is what it is.
Looks like more than a squeeze, this could be news.
There's alot of shenanigans going on with shorts making false accusations against CYDY.
$1,000 PX for CYDY is actually very realistic. With the amount of indications for Leronlimab it's very reasonable to believe it will do better than $1,000. It can reach $1,000 with 15 indications and so far there are over 20.
And after the NASDAQ uplist margin becomes available. Perfect opportunity to buy on the dips using house money.
Nice thing about the NASDAQ uplist is being able to trade after hours. But approval will be much better on OTC as the SP won't halt as it's gapping up.
So when CYDY uplist to NASDAQ I guess everything stays the same it will just say NASDAQ not OTC. I guess we'll find out Wednesday.
Hey justdafactss, after CYDY uplist to NASDAQ next week does the ticker stay the same?
I'm expecting CYDY PX $5.95